WuXi PharmaTech Schedules Fourth Quarter and Full Year 2007 Earnings Release on Wednesday, Marc...(+1-719-457-0820 / (UK)+0808-101- 1153. P...)
| HOME >> BIOLOGY >> TECHNOLOGY |
+1-719-457-0820 / (UK) +0808-101- 1153. Passcode: 2224172.
A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxipharmatech.com .
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech, headquartered in Shanghai, China, is the leading
global pharmaceutical, biotechnology and medical device R&D outsourcing
company. As a research-driven and customer-focused company, WuXi PharmaTech
provides pharmaceutical, biotechnology and medical device companies a broad
and integrated portfolio of laboratory, research manufacturing, biologics
testing and manufacturing services throughout the drug and medical device
research and development process. WuXi PharmaTech's services are designed
to assist its global partners in shortening the cycle and lowering the cost
of drug and medical device research and development by providing
cost-effective and efficient outsourcing solutions that save its customers
both time and money. For more information, please visit:
http://www.wuxipharmatech.com .
For more information, please contact:
Investor Contact:
Dr. Hai Mi, Vice President, Corporate Communications
WuXi PharmaTech Co., Ltd
Tel: +86-21-5046-3726
Email: ir@pharmatechs.com
Investor Relations (US):
Mahmoud Siddig, Director
Taylor Rafferty
Tel: +1-212-889-4350
Email: Pharmatechs@taylor-rafferty.com
Investor Relations (HK):
Ruby Yim, Managing Director
Taylor Rafferty
Tel: +852-3196-3712
Email: Pharmatechs@taylor-rafferty.com
Media Contact:
John Dooley
Taylor Rafferty
Tel: +1-212-889-4350
Email: Pharmatechs@taylor-rafferty.com
'/>"/>
| SOURCE WuXi PharmaTech (Cayman) Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. WuXi PharmaTech Completes Acquisition of AppTec
2. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
3. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
4. WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
5. WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO
6. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
7. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
8. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
9. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia
10. WuXi PharmaTech Announces Second Quarter 2007 Results
11. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |